UCB Announces Positive Results in Neurology and Inflammation Products

In neurology: Brivaracetam (ucb 34714), a high-affinity SV2A ligand target neurological virus plus epilepsy, have be evaluate bordered with a most primitive Phase II exploration including patients subsequent to photosensitive epilepsy. These grades will be presented at the American Epilepsy Society add in antagonism December 6th. The result of this study prove that brivaracetam provide a more potent and exclusive paroxysm suppression in these patients than shown once in study with Keppra, UCB's market anti-epileptic pills in Europe and US.

This confirm the impending and yawning anti-epileptic potential of the nearest and dearest of SV2A ligands. Seletracetam (ucb 44212), another high-affinity SV2A ligand has completed its first Phase I study in fluent volunteers demonstrating a giant tolerability and optimal PK profile. Phase II studies in epilepsy patients be deliberate and will be initiate hasty next year.

In inflammation: CDP323, an oral α4-integrin inhibitor, has victoriously completed a second Phase I multiple-dose study in healthy volunteers. Good plasma fair and potent and prolonged inhibition of ligand unchangeable to α4-integrins in an vitro integral blood assay be demonstrated. This confirms CDP323's anti-inflammatory potential in diseases such by the waste of multiple sclerosis.

The documents from today's template stereotype Business Review Meeting are accessible using the next web address: About the UCB Group UCB () be a worldwide pharmaceutical and specialty chemical viewpoint with headquarters in Brussels, Belgium.

When BYETTA be previously own hard by a drug that encompass a sulfonylurea, hypoglycemia (low blood sugar) is a likely rim effect. To cut this chance, the dose of sulfonylurea medicine may want to be reduced while using BYETTA. Other agreed side effects with BYETTA consist of nausea, vomiting, diarrhea, light-headedness, headache, outlook jittery, and tart front. Nausea is furthermost common when original starting BYETTA, but cut done juncture within most patients. BYETTA may reduce appetite, the amount of stores put away, and thing freight. These be not all the side effects with BYETTA. A healthcare provider should be consult in the zone of any side effect to be precise bothersome or do not disappear.

Cincinnati, OH (USA) - C Researchers at the University of Cincinnati College of Medicine presented grades of one of the largest smoke cessation trial ever conduct contained by the United States, STRATUS-US (STudies essential Rimonabant And Tobacco USe).

Information: UCB - Press contacts UCB - Investor Relations contacts Laurence Battaille Arnaud Denis Head of Corporate Communication Investor Relations Manager Tel.: +32 (2) 559 95 88 Tel.: +32 (2) 559 92 64

online pharmacy news tableta guide now